B

BridgeBio

Develops therapies for genetic diseases

Senior Project Manager

Clinical Research OperationsConfirmed live in the last 24 hours
Full-timeSan Francisco, CA, USA

About the Job

Requirements

  • Demonstrated understanding of the science behind drug development is required.
  • A minimum of 10 years of biotech/pharma industry project management experience.
  • Track record of delivering in a fast-paced, innovative, dynamic environment while remaining flexible, proactive, resourceful, and efficient.
  • Expert planning and tracking skills, ability to see the big picture, organization, focus on results, ability to manage multiple projects, time management concerning priorities, and self-management.
  • Ability to work strategically and independently with internal and external groups on multiple projects.
  • Some travel may be required (<10%) as appropriate.

Responsibilities

  • Organize and coordinate CMC/QA team activities and deliverables; manage weekly team meetings; prepare agendas and track action items.
  • Interface with and manage multiple CDMOs to drive manufacturing activities in alignment with CMC timelines and clinical and commercial supply needs.
  • Ensure adherence to agreed-upon team goals and deliverables; coordinate drafting of certain sections of regulatory filings and cross-functional reviews; organize document quality-control processes to ensure content accuracy.
  • Contribute to long-range planning and budgetary planning; work with Legal and Finance departments to drive and manage vendor contracts and purchase orders.
  • Manage multiple responsibilities and deliverables concurrently.

Desired Qualifications

  • M.S. or B.S. in chemistry or chemical engineering, or equivalent, is preferred.

About the Company

BridgeBio

Develops therapies for genetic diseases

BridgeBio Pharma develops medicines for genetic diseases using a decentralized subsidiary model, where each subsidiary focuses on a specific disease while sharing central resources. It advances multiple drug programs at once by leveraging genome sequencing, molecular biology, and patient data to translate research into therapies that target underlying genetic causes. The company differentiates itself through its independent subsidiary structure with centralized support, combined with data-driven decision making and a culture of transparent, evidence-based testing. Its goal is to bring effective, disease-modifying therapies to patients faster by advancing a diverse pipeline from discovery to commercialization through partnerships and eventual approval.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Palo Alto, CA
Founded
2014

Recently Posted Jobs

Explore more opportunities at BridgeBio

See more jobs